<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0033845" disease_type="Disease or Syndrome" abbrv="">Pseudotumor cerebri</z:e> (PTC) is a syndrome of <z:hpo ids='HP_0002516'>increased intracranial pressure</z:hpo> for which several risk factors have been described </plain></SENT>
<SENT sid="1" pm="."><plain>We report 2 patients who developed PTC after <z:chebi fb="0" ids="4031">cyclosporine</z:chebi> A (CsA) therapy for <z:e sem="disease" ids="C0018133" disease_type="Disease or Syndrome" abbrv="GVH">graft-versus-host disease</z:e> (GvHD) prevention after bone marrow transplant </plain></SENT>
<SENT sid="2" pm="."><plain>Both patients were <z:mp ids='MP_0001261'>obese</z:mp> which may have also contributed to the PTC </plain></SENT>
<SENT sid="3" pm="."><plain>Cessation of CsA and combinations of <z:chebi fb="0" ids="168396">mycophenolate</z:chebi> mofetil or tacrolimus and systemic steroids and/or acetazoleamide were effective in managing the symptoms, improving the ocular complications and keeping GvHD asymptomatic </plain></SENT>
<SENT sid="4" pm="."><plain>These cases suggest that induction of PTC by CsA used for GvHD prophylaxis in patients undergoing bone marrow transplant is not rare </plain></SENT>
<SENT sid="5" pm="."><plain>Physicians who are following patients on CsA need to be alert to the possibility of PTC </plain></SENT>
<SENT sid="6" pm="."><plain>Prompt diagnosis followed by thorough evaluation and treatment are crucial for preventing <z:hpo ids='HP_0000572'>visual loss</z:hpo> and improving associated symptoms </plain></SENT>
</text></document>